Annual Drug Patent Expirations for CHANTIX
Chantix is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from three suppliers. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for CHANTIX.
The generic ingredient in CHANTIX is varenicline tartrate. Three suppliers are listed for this compound. Additional details are available on the varenicline tartrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
